- News & Events
- Contact Us
Amgen Announces Award for Science Teaching ExcellenceFOR IMMEDIATE RELEASE
Louisville, KY - January 24, 2003 - Amgen (NASDAQ:AMGN) announced today the 2003 Amgen Award for Science Teaching Excellence, its recognition program for science education. One K-12 educator who teaches in either public or private schools in the Jefferson County school district will receive an unrestricted $10,000 award from Amgen, and will be honored at an award dinner in May.
For five years, Amgen has conducted the Amgen Award for Teacher Excellence in Jefferson County. Last year, the company modified the award to focus solely on excellence in science teaching. Amgen also conducts similar programs in California; Colorado; Puerto Rico; Rhode Island; and Seattle, Washington.
Anyone can nominate an educator who teaches science. The nomination letter should include: the full name of the teacher; the name and address of the school; the name of the school district; the school's phone number; the grade level the science teacher teaches; the nominator's relationship to the science teacher; the nominator's phone number; and a description of why the science teacher deserves the award. The letter should describe the teacher's attributes in the areas of creativity, teaching effectiveness, best practice development, and instructional and motivational ability.
Letters should be sent to: Amgen Award for Science Teaching Excellence, Sandra Klein, Amgen Inc., 12000 Plantside Drive, Louisville, KY 40299. Nominations can also be submitted electronically, at www.Amgen.com/corporate/AmgenTeacher/index.html . Nominations for the award will be accepted immediately, through February 28, 2003.
Amgen is a global biotechnology company that discovers, develops, manufactures and markets important human therapeutics based on advances in cellular and molecular biology.
Amgen, Thousand Oaks
Barbara Bronson Gray: 805/447-4949
Amgen, Corporate Communications
EDITOR'S NOTES: An electronic version of this news release may be accessed via our web site at http://www.amgen.com.